Latest News for BRCTF
STOCKHOLM, Feb. 27, 2026 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company issued 78,000 Class B shares during February for delivery of shares to participants in the 2019/2028 stock option program resolved at the Annual General Meeting on May 9, 2019. The shares were issued through an exercise of 78,000 stock options of series 2019/2028.
BioArctic AB (publ) (BRCTF) Q4 2025 Earnings Call Transcript
STOCKHOLM, Feb. 18, 2026 /PRNewswire/ -- A transformative year with record financial results Events during the fourth quarter 2025 Leqembi® Iqlik™ was launched for weekly maintenance dosing and Eisai completed rolling sBLA submission for subcutaneous initiation treatment in the US Leqembi was approved in Brazil and Canada Leqembi was approved for IV maintenance treatment in the United Kingdom Eisai submitted…
STOCKHOLM, Feb. 11, 2026 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) will publish the company's fourth quarter report for October - December 2025 on Wednesday, February 18, 2026, at 08:00 a.m. CET. In conjunction with the report, BioArctic invites investors, analysts, and media to a presentation on February 18, at 09:30 a.m.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BRCTF.
Senate Trading
No Senate trades found for BRCTF.
U.S. House Trading
No House trades found for BRCTF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.